ReviewBasic & clinical pharmacology & toxicology2026
Plant-Derived Heterocyclic Compounds: A Promising Review on Natural Remedies for Rheumatoid Arthritis Management and Their Mechanistic Insights in Inflammation and Joint Protection.
Review in Basic & clinical pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Rheumatoid arthritis (RA) represents a persistent autoimmune disease that causes continuous joint inflammation and results in synovial tissue overgrowth and worsening cartilage breakdown together with degeneration of bones. The existing pharmaceutical treatments provide symptom management although they create important adverse effects and raise ongoing security concerns. Plant-derived heterocyclic compounds present themselves as promising pharmaceutical substitution options because they demonstrate a wide spectrum of bioactivities that include anti-inflammatory protection together with immunomodulatory and antioxidative properties. This review investigates the therapeutic properties of natural heterocyclic compounds principally including flavonoids, alkaloids, coumarins and terpenoids for RA treatment. Medical plants contain these abundant compounds that adjust inflammatory pathways consisting of NF-κB, MAPK and JAK/STAT to decrease pro-inflammatory cytokines TNF-α, IL-1β and IL-6 and restrict synovial fibroblast proliferation. The heterocyclic compounds found in medicinal plants also protect joints through two mechanisms: by improving antioxidant defences and activating cartilage repair. In addition to laboratory and animal test results the study evaluates how these natural compounds work together when combined in treatment plans. Research into structure-activity interactions of heterocyclic compounds alongside their molecular targets enables better development of safe plant-derived drugs. The research review demonstrates that plant-derived heterocyclic compounds need to become essential components in treating RA while promoting clinical studies to determine their human subject action and mechanism of operation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.